BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37507528)

  • 1. Post-chemotherapy robot-assisted retroperitoneal lymph node dissection for metastatic germ cell tumors: safety and perioperative outcomes.
    Branger N; Bladou F; Verhoest G; Knipper S; Robert G; Bernhard JC; Beauval JB; Khaddad A; Mauger De Varennes A; Fléchon A; Walz J; Bageot AS; Doumerc N; Rouprêt M; Murez T;
    World J Urol; 2023 Sep; 41(9):2405-2411. PubMed ID: 37507528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of post-chemotherapy robot-assisted retroperitoneal lymph node dissection in testicular cancer: multi-institutional study.
    Abdul-Muhsin H; Rocco N; Navaratnam A; Woods M; L'Esperance J; Castle E; Stroup S
    World J Urol; 2021 Oct; 39(10):3833-3838. PubMed ID: 33959785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Robotic Assisted Retroperitoneal Lymph Node Dissection for Small Volume Metastatic Testicular Cancer.
    Hiester A; Nini A; Arsov C; Buddensieck C; Albers P
    J Urol; 2020 Dec; 204(6):1242-1248. PubMed ID: 32717162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Robot-assisted Laparoscopic Retroperitoneal Lymph Node Dissection for Testicular Cancer: Evolution of the Technique.
    Stepanian S; Patel M; Porter J
    Eur Urol; 2016 Oct; 70(4):661-667. PubMed ID: 27068395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Midline Extraperitoneal Approach to Retroperitoneal Lymph Node Dissection in Testicular Cancer: Minimizing Surgical Morbidity.
    Syan-Bhanvadia S; Bazargani ST; Clifford TG; Cai J; Miranda G; Daneshmand S
    Eur Urol; 2017 Nov; 72(5):814-820. PubMed ID: 28325537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Early Oncologic Effectiveness of Primary Robotic Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Testicular Cancer.
    Pearce SM; Golan S; Gorin MA; Luckenbaugh AN; Williams SB; Ward JF; Montgomery JS; Hafez KS; Weizer AZ; Pierorazio PM; Allaf ME; Eggener SE
    Eur Urol; 2017 Mar; 71(3):476-482. PubMed ID: 27234998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trans- and extraperitoneal retroperitoneal lymph node dissection (RPLND) in the treatment for nonseminomatous germ cell testicular tumors (NSGCT): a single Chinese center's retrospective analysis.
    Tong S; Chen M; Zu X; Li Y; He W; Lei Y; Liu W; Qi L
    Int Urol Nephrol; 2014 Feb; 46(2):363-9. PubMed ID: 23996573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Robot-assisted post-chemotherapy retroperitoneal lymph node dissection in germ cell tumor: is the single-docking with lateral approach relevant?
    Overs C; Beauval JB; Mourey L; Rischmann P; Soulié M; Roumiguié M; Doumerc N
    World J Urol; 2018 Apr; 36(4):655-661. PubMed ID: 29353314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-chemotherapy laparoscopic retroperitoneal lymph node dissection is feasible for stage IIA/B non-seminoma germ cell tumors.
    Nakamura T; Kawauchi A; Oishi M; Ueda T; Shiraishi T; Nakanishi H; Kamoi K; Naya Y; Hongo F; Okihara K; Miki T
    Int J Clin Oncol; 2016 Aug; 21(4):791-795. PubMed ID: 26701172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary Robot-assisted Retroperitoneal Lymph Node Dissection for Men with Nonseminomatous Germ Cell Tumor: Experience from a Multi-institutional Cohort.
    Taylor J; Becher E; Wysock JS; Lenis AT; Litwin MS; Jipp J; Langenstroer P; Johnson S; Bjurlin MA; Tan HJ; Lane BR; Huang WC
    Eur Urol Focus; 2021 Nov; 7(6):1403-1408. PubMed ID: 32682794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-chemotherapy nerve-sparing laparoscopic retroperitoneal lymph node dissection in stage IIB testicular cancer.
    Kimura Y; Nakamura T; Kawauchi A; Kawabata G; Hongo F; Miki T
    Int J Urol; 2013 Aug; 20(8):837-41. PubMed ID: 23305547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robotic post-chemotherapy retroperitoneal lymph node dissection for testicular cancer: A multicenter collaborative study.
    Ghoreifi A; Mitra AP; McClintock G; Baky F; McDowell Z; Lavallée E; Saoud R; Cai J; Gill IS; Sfakianos J; Porter J; Bagrodia A; Ahmadi N; Eggener S; Ward JF; Djaladat H
    Urol Oncol; 2023 Feb; 41(2):111.e7-111.e14. PubMed ID: 36437156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative complications and oncological outcomes of post-chemotherapy retroperitoneal lymph node dissection in patients with germ cell cancer at two high-volume university centres in Switzerland - a retrospective chart review.
    Notarfrancesco M; Fankhauser CD; Lorch A; Ardizzone D; Helnwein S; Hoch D; Hermanns T; Thalmann G; Beyer J
    Swiss Med Wkly; 2023 Apr; 153():40053. PubMed ID: 37080191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laparoscopic Postchemotherapy Retroperitoneal Lymph-Node Dissection Can Be a Standard Option in Defined Nonseminomatous Germ Cell Tumor Patients.
    Nicolai N; Cattaneo F; Biasoni D; Catanzaro M; Torelli T; Zazzara M; Necchi A; Giannatempo P; Raggi D; Piva L; Colecchia M; Salvioni R; Stagni S
    J Endourol; 2016 Oct; 30(10):1112-1119. PubMed ID: 27533924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Outcome of Patients with Fibrosis/Necrosis at Post-Chemotherapy Retroperitoneal Lymph Node Dissection for Advanced Germ Cell Tumors.
    Mano R; Becerra MF; Carver BS; Bosl GJ; Motzer RJ; Bajorin DF; Feldman DR; Sheinfeld J
    J Urol; 2017 Feb; 197(2):391-397. PubMed ID: 27720783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-Chemotherapy Robotic Retroperitoneal Lymph Node Dissection: Institutional Experience.
    Kamel MH; Littlejohn N; Cox M; Eltahawy EA; Davis R
    J Endourol; 2016 May; 30(5):510-9. PubMed ID: 26669219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumor: a large single institution experience.
    Hyams ES; Pierorazio P; Proteek O; Sroka M; Kavoussi LR; Allaf ME
    J Urol; 2012 Feb; 187(2):487-92. PubMed ID: 22177913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-chemotherapy retroperitoneal lymph node dissection in the management of metastatic testis cancer: the 16-year experience in an Irish setting.
    Considine S; Heaney R; Conroy R; Thornhill JA
    Ir J Med Sci; 2016 Nov; 185(4):901-907. PubMed ID: 26692387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Effectiveness of Surveillance, Primary Chemotherapy, Radiotherapy and Retroperitoneal Lymph Node Dissection for the Management of Early Stage Testicular Germ Cell Tumors: A Systematic Review.
    Pierorazio PM; Cheaib JG; Patel HD; Gupta M; Sharma R; Zhang A; Tema G; Bass EB
    J Urol; 2021 Feb; 205(2):370-382. PubMed ID: 32915080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical outcome of postchemotherapy retroperitoneal lymph node dissection and predicting retroperitoneal histology in advanced nonseminomatous germ cell tumours of the testis].
    Li XD; Guo SJ; Chen SL; Liu ZF; Dong P; Zhang ZL; Jiang LJ; Yao K; Li YH; Han H; Qin ZK; Liu ZW; Zhou FJ
    Zhonghua Wai Ke Za Zhi; 2017 Aug; 55(8):603-607. PubMed ID: 28789511
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.